We value your privacy

We use cookies to enhance your browsing experience, serve personalized ads or content, and analyze our traffic. The Administrator of personal data is STOCKTRADEIQ sp. z o.o., with its registered office in Poznan (61-625), at the following address: Czarna Rola 30 Street. Cookies policy here. By clicking "Accept All", you consent to our use of cookies.

Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

  • Cookie
    cookieyes-consent
  • Duration
    1 year
  • Description
    CookieYes sets this cookie to remember users' consent preferences so that their preferences are respected on their subsequent visits to this site. It does not collect or store any personal information of the site visitors.
  • Cookie
    x-ms-cpim-csrf
  • Duration
    session
  • Description

    Inter-site request forgery token used to protect crSF. For more information, read the section Token falsification of requests between sites.

  • Cookie
    x-ms-cpim-sso:stocktradeiqauth.onmicrosoft.com_0
  • Duration
    session
  • Description

    Used to support single sign-on sessions. This cookie is set as persistent when the Keep me logged in option is enabled.

  • Cookie
    server-telemetry-{id}
  • Duration
    persistent
  • Description

    A value used by Microsoft for authorisation and authentication.

  • Cookie
    google_auto_fc_cmp_setting
  • Duration
    persistent
  • Description


    Stores the state of the User cookie for the current domain.

     

  • Cookie
    {id}-https://stocktradeiqauth.onmicrosoft.com/{id}
  • Duration
    persistent
  • Description

    Stores information about the logged-in user's session.

  • Cookie
    msal{id}.active-account
  • Duration
    persistent
  • Description

    Stores information about the logged-in user's session.

  • Cookie
    {id}signinup{id}stocktradeiqauth.b2clogin.com-refreshtoken
  • Duration
    persistent
  • Description

    Stores information about the logged-in user's session.

  • Cookie
    {id}signinup{id}stocktradeiqauth.b2clogin.com-idtoken
  • Duration
    persistent
  • Description

    Stores information about the logged-in user's session.

  • Cookie
    {id}signinup{id}stocktradeiqauth.b2clogin.com
  • Duration
    persistent
  • Description

    Stores information about the logged-in user's session.

  • Cookie
    Microsoft Clarity
  • Duration
    1 year
  • Description

    Microsoft Clarity

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

  • Cookie
    isLightMode
  • Duration
    1 year
  • Description

    Defines the UI theme

  • Cookie
    userCultureData
  • Duration
    persistent
  • Description

     Stores information about the user's machine culture.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

  • Cookie
    _ga
  • Duration
    1 year 1 month 4 days
  • Description
    The _ga cookie, installed by Google Analytics, calculates visitor, session and campaign data and also keeps track of site usage for the site's analytics report. The cookie stores information anonymously and assigns a randomly generated number to recognize unique visitors.
  • Cookie
    _ga_*
  • Duration
    1 year 1 month 4 days
  • Description
    Google Analytics sets this cookie to store and count page views.
  • Cookie
    hotjar
  • Duration
    1 year 1 month 4 days
  • Description

    Analyzing users' behaviour in the website

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

  • Cookie
    __gpi
  • Duration
    1 year 24 days
  • Description
    Google Ads Service uses this cookie to collect information about from multiple websites for retargeting ads.
  • Cookie
    __gads
  • Duration
    1 year 24 days
  • Description

    The file, set by Google, is stored in the DoubleClick domain and tracks the number of times users view an ad, measures the success of the campaign and calculates its revenue. This cookie can only be read from the domain where it is set and does not track any data when browsing other sites.

  • Cookie
    goog:cached:topics
  • Duration
    persistent
  • Description

    It is used to record which adverts have been displayed to the User.

  • Cookie
    IDE
  • Duration
    year
  • Description

    Used by Google DoubleClick to record and report on the Website User's actions after viewing or clicking on an advertiser's ads in order to measure the effectiveness of the ad and present the User with targeted advertising.

  • Cookie
    google_experiment_mod44
  • Duration
    persistent
  • Description

    Used by Google Ad to experiment with the effectiveness of ads on websites using their services.

Powered by Cookieyes logo

    Get Diamond plan for FREE

    logo

    AIkido Pharma Inc. (AIKI)

    Price:

    3.56 USD

    ( + 0.03 USD)

    Your position:

    0 USD

    ACTION PANEL
    CREATE A NOTE
    ABOUT
    Symbol
    AIKI
    Name
    AIkido Pharma Inc.
    Industry
    Biotechnology
    Sector
    Healthcare
    Price
    3.560
    Market Cap
    19.527M
    Enterprise value
    20.973M
    Currency
    USD
    Ceo
    Anthony C. Hayes
    Full Time Employees
    4
    Website
    aikidopharma.com
    Ipo Date
    1980-03-18
    City
    New York City
    Address
    ONE ROCKEFELLER PLAZA, 11TH FLOOR

    Check the

    KEY TAKEAWAYS

    ASK OUR AI ABOUT THE COMPANY (REGISTER FOR EARLY ACCESS)
    Descriptive alt text

    (REGISTER FOR EARLY ACCESS) CHOOSE A PROMPT ABOVE TO ASK OUR AI ABOUT THE SPECIFIC INFORMATION

    SIMILAR COMPANIES STI SCORE

    Similar STI Score

    BioNTech SE

    VALUE SCORE:

    6

    Symbol
    BNTX
    Market Cap
    22.417B
    Industry
    Biotechnology
    Sector
    Healthcare

    2nd position

    ADMA Biologics, Inc.

    VALUE SCORE:

    11

    Symbol
    ADMA
    Market Cap
    3.775B
    Industry
    Biotechnology
    Sector
    Healthcare

    The best

    Harmony Biosciences Holdings, Inc.

    VALUE SCORE:

    12

    Symbol
    HRMY
    Market Cap
    1.624B
    Industry
    Biotechnology
    Sector
    Healthcare
    FUNDAMENTALS
    P/E
    0.469
    P/S
    0.546
    P/B
    0.246
    Debt/Equity
    0.014
    EV/FCF
    -7.171
    Price to operating cash flow
    -1.000
    Price to free cash flow
    -1.000
    EV/sales
    0.522
    Earnings yield
    2.134
    Debt/assets
    0.013
    FUNDAMENTALS
    Net debt/ebidta
    -0.033
    Interest coverage
    0
    Research And Developement To Revenue
    0
    Intangile to total assets
    0
    Capex to operating cash flow
    0
    Capex to revenue
    0
    Capex to depreciation
    0
    Return on tangible assets
    0.494
    Debt to market cap
    0.055
    Piotroski Score
    5.000
    FUNDAMENTALS
    PEG
    170.809
    P/CF
    -11.513
    P/FCF
    -4.424
    RoA %
    49.463
    RoIC %
    -25.787
    Gross Profit Margin %
    -0.939
    Quick Ratio
    27.543
    Current Ratio
    27.543
    Net Profit Margin %
    100.348
    Net-Net
    11.961
    FUNDAMENTALS PER SHARE
    FCF per share
    -0.469
    Revenue per share
    6.449
    Net income per share
    7.149
    Operating cash flow per share
    -0.469
    Free cash flow per share
    -0.469
    Cash per share
    11.411
    Book value per share
    13.618
    Tangible book value per share
    13.618
    Shareholders equity per share
    13.609
    Interest debt per share
    0.194
    TECHNICAL
    52 weeks high
    7.267
    52 weeks low
    0.290
    Current trading session High
    3.660
    Current trading session Low
    3.500
    DIVIDEND
    Dividend yield
    19.5%
    Payout ratio
    10.9%
    Years of div. Increase
    0
    Years of div.
    0
    Q-shift
    Dividend per share
    0.652
    SIMILAR COMPANIES
    logo
    Country
    US
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.576

    No data to display

    logo
    Country
    US
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -1.455

    No data to display

    logo
    Country
    US
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -2.890

    No data to display

    logo
    Country
    US
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.124

    No data to display

    logo
    Country
    US
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.227
    logo
    Country
    IL
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.673

    No data to display

    logo
    Country
    GB
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    5.848

    No data to display

    logo
    Country
    US
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -1.030
    logo
    Country
    US
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -22.510

    No data to display

    DESCRIPTION

    AIkido Pharma Inc., a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia. The company is also developing an antiviral platform that inhibits replication of viruses, including influenza virus, Ebolavirus and Marburg virus, SARS-CoV, MERS-CoV, and SARS-CoV-2. It has license agreements with the University of Texas, University of Maryland Baltimore, Silo Pharma Inc., and Wake Forest University Health Sciences. The company was formerly known as Spherix Incorporated and changed its name to AIkido Pharma Inc. in March 2021. AIkido Pharma Inc. was founded in 1967 and is headquartered in New York, New York.

    NEWS
    https://images.financialmodelingprep.com/news/why-is-aikido-pharma-aiki-stock-up-1400-20220607.jpg
    Why Is AIkido Pharma (AIKI) Stock Up 1,400%?

    investorplace.com

    2022-06-07 10:39:50

    AIkido Pharma (AIKI) stock is skyrocketing on Tuesday but it's not due to any positive news from the biotechnology company. The post Why Is AIkido Pharma (AIKI) Stock Up 1,400%?

    https://images.financialmodelingprep.com/news/aikido-pharma-aiki-stock-price-1for17-reverse-split-goes-20220607.jpg
    Aikido Pharma (AIKI) Stock Price: 1-For-17 Reverse Split Goes Into Effect

    pulse2.com

    2022-06-07 08:27:57

    A 1 for 17 reverse stock split of AIkido Pharma, Inc. (NASDAQ: AIKI) has gone into effect. These are the details.

    https://images.financialmodelingprep.com/news/trending-penny-stocks-to-watch-after-holiday-season-20220102.jpg
    Trending Penny Stocks to Watch After Holiday Season

    pennystocks.com

    2022-01-02 17:00:00

    Which penny stocks are you watching right now? The post Trending Penny Stocks to Watch After Holiday Season appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

    https://images.financialmodelingprep.com/news/5-top-penny-stocks-to-watch-under-1-after-20211101.jpg
    5 Top Penny Stocks To Watch Under $1 After CSCW Stock Explodes

    pennystocks.com

    2021-11-01 15:23:58

    There are so many traders looking for the best penny stocks 2021… The post 5 Top Penny Stocks To Watch Under $1 After CSCW Stock Explodes appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

    https://images.financialmodelingprep.com/news/best-penny-stocks-to-buy-right-now-3-to-20211101.jpg
    Best Penny Stocks to Buy Right Now? 3 to Watch This Month

    pennystocks.com

    2021-11-01 09:20:51

    If you're making a penny stocks watchlist in November, here's three you should check out The post Best Penny Stocks to Buy Right Now? 3 to Watch This Month appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

    https://images.financialmodelingprep.com/news/best-penny-stocks-to-buy-in-november-3-you-need-20211030.jpg
    Best Penny Stocks to Buy in November? 3 You Need to Know About

    pennystocks.com

    2021-10-30 11:30:00

    Are these penny stocks on your November watchlist? The post Best Penny Stocks to Buy in November?

    https://images.financialmodelingprep.com/news/trumplinked-spac-has-traders-also-focused-on-these-6-20211022.jpg
    Trump-Linked SPAC Has Traders Also Focused On These 6 Stocks

    benzinga.com

    2021-10-22 14:36:44

    The second half of October has been one of the most active periods for the stock market in quite some time. Not only did the major indexes, including the SPDR S&P 500 ETF (NYSE: SPY) and SPDR Dow Jones Industrial Average ETF Trust (NYSE: DIA) hit fresh, all-time highs, retail traders, are finally getting their fill of volatile small-caps and short squeeze stocks.

    https://images.financialmodelingprep.com/news/5-top-penny-stocks-analysts-say-to-buy-now-20211011.jpg
    5 Top Penny Stocks Analysts Say To Buy Now With 123%-733% Targets

    pennystocks.com

    2021-10-11 10:02:09

    Will these penny stocks meet analysts' expectations? The post 5 Top Penny Stocks Analysts Say To Buy Now With 123%-733% Targets appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

    https://images.financialmodelingprep.com/news/aikido-pharma-trading-30-below-cash-value-despite-positive-20211006.jpg
    AIkido Pharma Trading 30% Below Cash Value Despite Positive Indications

    benzinga.com

    2021-10-06 09:27:49

    Photo by Joshua Mayo on Unsplash Biotechnology development company AIkido Pharma Inc. (NASDAQ: AIKI) recently released its 1st-quarter report, which revealed the strongest balance sheet in the company's history with approximately $102 million in cash and cash equivalents.

    https://images.financialmodelingprep.com/news/top-penny-stocks-to-watch-as-october-gets-off-20211001.jpg
    Top Penny Stocks to Watch As October Gets Off to a Bullish Start

    pennystocks.com

    2021-10-01 15:42:14

    October is getting off to a great start for penny stocks, here's three to watch The post Top Penny Stocks to Watch As October Gets Off to a Bullish Start appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

    https://images.financialmodelingprep.com/news/5-penny-stocks-to-watch-under-1-after-cei-20210928.jpg
    5 Penny Stocks To Watch Under $1 After CEI Stock's 900% Rally

    pennystocks.com

    2021-09-28 12:00:06

    Best penny stocks to watch under $1? The post 5 Penny Stocks To Watch Under $1 After CEI Stock's 900% Rally appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

    https://images.financialmodelingprep.com/news/aikido-pharma-secures-interest-in-electric-truck-maker-tevva-20210928.jpg
    AIkido Pharma Secures Interest in Electric Truck Maker, Tevva Motors Ltd

    prnewswire.com

    2021-09-28 10:45:00

    NEW YORK, Sept. 28, 2021 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today announced that the Company secured an equity interest in Tevva Motors Ltd, an electric truck producer with range extended vehicles on the road now.

    https://images.financialmodelingprep.com/news/are-biotech-penny-stocks-worth-buying-check-these-3-20210920.jpg
    Are Biotech Penny Stocks Worth Buying? Check These 3 Out

    pennystocks.com

    2021-09-20 14:30:00

    Biotech penny stocks are heating up right now, here's three to watch The post Are Biotech Penny Stocks Worth Buying? Check These 3 Out appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

    https://images.financialmodelingprep.com/news/aikido-pharma-secures-interest-in-growing-telehealth-company-20210920.jpg
    AIkido Pharma Secures Interest in Growing Tele-health Company

    prnewswire.com

    2021-09-20 09:00:00

    NEW YORK, Sept. 20, 2021 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today announced that the Company secured an early equity interest in tele-health company, Kerna Health (https://kernahealth.com).

    https://images.financialmodelingprep.com/news/aikido-provides-update-on-use-of-machine-learning-in-20210806.jpg
    AIkido Provides Update on Use of Machine Learning in Drug Development Program

    prnewswire.com

    2021-08-06 10:00:00

    NEW YORK, Aug. 6, 2021 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today provided and update on the use of Machine Learning in support of its antiviral platform with the University of Maryland Baltimore School of Medicine.  The Company stated:  The goal for the project is the identification and optimization of anti-viral compounds that inhibit viral replication by targeting a protein complex that degrades RNA at the cellular level.

    https://images.financialmodelingprep.com/news/notice-of-allowance-issued-for-central-nervous-system-peptide-20210727.jpg
    Notice of Allowance Issued for Central Nervous System Peptide Technology

    prnewswire.com

    2021-07-27 10:00:00

    NEW YORK, July 27, 2021 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today announced that the U.S. Patent and Trademark Office has issued a Notice of Allowance for application No.: 16/477,125.